CORC

浏览/检索结果: 共396条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Bag of Tricks for Training Data Extraction from Language Models 会议论文
Hawaii, US, 2023-7
作者:  Yu, Weichen;  Pang, Tianyu;  Liu, Qian;  Du, Chao;  Kang, Bingyi
收藏  |  浏览/下载:10/0  |  提交时间:2023/07/03
Study on the Measurement and Residual Dose of the CSNS Stripping Foil 会议论文
Brazil, 2021
作者:  M.Y. Huang;  L. Kang;  S. Wang;  Q.B. Wu, S.Y. Xu;  Y.L. Zhang
收藏  |  浏览/下载:31/0  |  提交时间:2022/01/18
Ground experiment of a 50 mm balloon-borne coronagraph for near space project 会议论文
Chengdu, China, 2021-06-14
作者:  Liu Y(刘煜);  Zhang XF(张雪飞);  Song TF(宋腾飞);  Sun, Mingzhe;  Liu, Dayang
收藏  |  浏览/下载:57/0  |  提交时间:2022/03/07
Calcined ZnNiAl hydrotalcite-like compounds as bifunctional catalysts for carbonyl sulfide removal 会议论文
Tianjin Univ, Tianjin, PEOPLES R CHINA, OCT 16-20, 2017
作者:  Zhao, Shunzheng;  Yi, Honghong;  Tang, Xiaolong;  Kang, Dongjuan;  Gao, Fengyu
收藏  |  浏览/下载:71/0  |  提交时间:2019/06/21
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:44/0  |  提交时间:2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载:140/0  |  提交时间:2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace